Umoja Biopharma Appoints Dr. Robert Glassman to its Board of Directors

SEATTLE, Jan. 25, 2021 /PRNewswire/ -- Umoja Biopharma, a biotechnology company pioneering an integrated, in vivo immunotherapy platform, today announced the appointment of Rob Glassman, M.D., to its Board of Directors...
Login to comment.